PROPHYLAXIS AND TREATMENT OF THROMBOEMBOLISM III NEW ORAL ANTICOAGULANTS. RESULTS OF PIVOTAL TRIALS IN ORTHOPEDIC SURGERY THE RIVAROXABAN PROGRAM